The most common heart rhythm disorder, atrial fibrillation (AF, or afib) is a serious global public health problem which affects millions of people around the world. If left untreated, AF doubles the risk of heart-related deaths and also increases stroke risk by up to 500%. Unfortunately, although it is such a serious health problem, AF has historically been difficult to treat with an acceptable degree of success.
In response to this unaddressed need, Topera, Inc. has developed a unique 3D analysis and mapping solution (the Topera 3D Mapping System), which consists of the RhythmView Workstation and FIRMap diagnostic catheter. The Topera 3D Mapping System has been designed to enable physicians to view the electrical activity of the heart, thereby supporting the diagnosis and patient-specific treatment planning for a variety of heart arrhythmias including atrial fibrillation, atrial flutter, atrial tachycardia, and ventricular tachycardia.
The Topera 3D Mapping System received FDA clearance in 2013 and is now in routine use at several leading medical centers throughout the United States.